Cargando…
Evaluating more naturalistic outcome measures: A 1-year smartphone study in multiple sclerosis
OBJECTIVE: In this cohort of individuals with and without multiple sclerosis (MS), we illustrate some of the novel approaches that smartphones provide to monitor patients with chronic neurologic disorders in their natural setting. METHODS: Thirty-eight participant pairs (MS and cohabitant) aged 18–5...
Autores principales: | , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4608760/ https://www.ncbi.nlm.nih.gov/pubmed/26516627 http://dx.doi.org/10.1212/NXI.0000000000000162 |
_version_ | 1782395711693783040 |
---|---|
author | Bove, Riley White, Charles C. Giovannoni, Gavin Glanz, Bonnie Golubchikov, Victor Hujol, Johnny Jennings, Charles Langdon, Dawn Lee, Michelle Legedza, Anna Paskavitz, James Prasad, Sashank Richert, John Robbins, Allison Roberts, Susan Weiner, Howard Ramachandran, Ravi Botfield, Martyn De Jager, Philip L. |
author_facet | Bove, Riley White, Charles C. Giovannoni, Gavin Glanz, Bonnie Golubchikov, Victor Hujol, Johnny Jennings, Charles Langdon, Dawn Lee, Michelle Legedza, Anna Paskavitz, James Prasad, Sashank Richert, John Robbins, Allison Roberts, Susan Weiner, Howard Ramachandran, Ravi Botfield, Martyn De Jager, Philip L. |
author_sort | Bove, Riley |
collection | PubMed |
description | OBJECTIVE: In this cohort of individuals with and without multiple sclerosis (MS), we illustrate some of the novel approaches that smartphones provide to monitor patients with chronic neurologic disorders in their natural setting. METHODS: Thirty-eight participant pairs (MS and cohabitant) aged 18–55 years participated in the study. Each participant received an Android HTC Sensation 4G smartphone containing a custom application suite of 19 tests capturing participant performance and patient-reported outcomes (PROs). Over 1 year, participants were prompted daily to complete one assigned test. RESULTS: A total of 22 patients with MS and 17 cohabitants completed the entire study. Among patients with MS, low scores on PROs relating to mental and visual function were associated with dropout (p < 0.05). We illustrate several novel features of a smartphone platform. First, fluctuations in MS outcomes (e.g., fatigue) were assessed against an individual's ambient environment by linking responses to meteorological data. Second, both response accuracy and speed for the Ishihara color vision test were captured, highlighting the benefits of both active and passive data collection. Third, a new trait, a person-specific learning curve in neuropsychological testing, was identified using spline analysis. Finally, averaging repeated measures over the study yielded the most robust correlation matrix of the different outcome measures. CONCLUSIONS: We report the feasibility of, and barriers to, deploying a smartphone platform to gather useful passive and active performance data at high frequency in an unstructured manner in the field. A smartphone platform may therefore enable large-scale naturalistic studies of patients with MS or other neurologic diseases. |
format | Online Article Text |
id | pubmed-4608760 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-46087602015-10-29 Evaluating more naturalistic outcome measures: A 1-year smartphone study in multiple sclerosis Bove, Riley White, Charles C. Giovannoni, Gavin Glanz, Bonnie Golubchikov, Victor Hujol, Johnny Jennings, Charles Langdon, Dawn Lee, Michelle Legedza, Anna Paskavitz, James Prasad, Sashank Richert, John Robbins, Allison Roberts, Susan Weiner, Howard Ramachandran, Ravi Botfield, Martyn De Jager, Philip L. Neurol Neuroimmunol Neuroinflamm Article OBJECTIVE: In this cohort of individuals with and without multiple sclerosis (MS), we illustrate some of the novel approaches that smartphones provide to monitor patients with chronic neurologic disorders in their natural setting. METHODS: Thirty-eight participant pairs (MS and cohabitant) aged 18–55 years participated in the study. Each participant received an Android HTC Sensation 4G smartphone containing a custom application suite of 19 tests capturing participant performance and patient-reported outcomes (PROs). Over 1 year, participants were prompted daily to complete one assigned test. RESULTS: A total of 22 patients with MS and 17 cohabitants completed the entire study. Among patients with MS, low scores on PROs relating to mental and visual function were associated with dropout (p < 0.05). We illustrate several novel features of a smartphone platform. First, fluctuations in MS outcomes (e.g., fatigue) were assessed against an individual's ambient environment by linking responses to meteorological data. Second, both response accuracy and speed for the Ishihara color vision test were captured, highlighting the benefits of both active and passive data collection. Third, a new trait, a person-specific learning curve in neuropsychological testing, was identified using spline analysis. Finally, averaging repeated measures over the study yielded the most robust correlation matrix of the different outcome measures. CONCLUSIONS: We report the feasibility of, and barriers to, deploying a smartphone platform to gather useful passive and active performance data at high frequency in an unstructured manner in the field. A smartphone platform may therefore enable large-scale naturalistic studies of patients with MS or other neurologic diseases. Lippincott Williams & Wilkins 2015-10-15 /pmc/articles/PMC4608760/ /pubmed/26516627 http://dx.doi.org/10.1212/NXI.0000000000000162 Text en © 2015 American Academy of Neurology This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License 4.0 (CC BY-NC-ND) (http://creativecommons.org/licenses/by-nc-nd/4.0/) , which permits downloading and sharing the work provided it is properly cited. The work cannot be changed in any way or used commercially. |
spellingShingle | Article Bove, Riley White, Charles C. Giovannoni, Gavin Glanz, Bonnie Golubchikov, Victor Hujol, Johnny Jennings, Charles Langdon, Dawn Lee, Michelle Legedza, Anna Paskavitz, James Prasad, Sashank Richert, John Robbins, Allison Roberts, Susan Weiner, Howard Ramachandran, Ravi Botfield, Martyn De Jager, Philip L. Evaluating more naturalistic outcome measures: A 1-year smartphone study in multiple sclerosis |
title | Evaluating more naturalistic outcome measures: A 1-year smartphone study in multiple sclerosis |
title_full | Evaluating more naturalistic outcome measures: A 1-year smartphone study in multiple sclerosis |
title_fullStr | Evaluating more naturalistic outcome measures: A 1-year smartphone study in multiple sclerosis |
title_full_unstemmed | Evaluating more naturalistic outcome measures: A 1-year smartphone study in multiple sclerosis |
title_short | Evaluating more naturalistic outcome measures: A 1-year smartphone study in multiple sclerosis |
title_sort | evaluating more naturalistic outcome measures: a 1-year smartphone study in multiple sclerosis |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4608760/ https://www.ncbi.nlm.nih.gov/pubmed/26516627 http://dx.doi.org/10.1212/NXI.0000000000000162 |
work_keys_str_mv | AT boveriley evaluatingmorenaturalisticoutcomemeasuresa1yearsmartphonestudyinmultiplesclerosis AT whitecharlesc evaluatingmorenaturalisticoutcomemeasuresa1yearsmartphonestudyinmultiplesclerosis AT giovannonigavin evaluatingmorenaturalisticoutcomemeasuresa1yearsmartphonestudyinmultiplesclerosis AT glanzbonnie evaluatingmorenaturalisticoutcomemeasuresa1yearsmartphonestudyinmultiplesclerosis AT golubchikovvictor evaluatingmorenaturalisticoutcomemeasuresa1yearsmartphonestudyinmultiplesclerosis AT hujoljohnny evaluatingmorenaturalisticoutcomemeasuresa1yearsmartphonestudyinmultiplesclerosis AT jenningscharles evaluatingmorenaturalisticoutcomemeasuresa1yearsmartphonestudyinmultiplesclerosis AT langdondawn evaluatingmorenaturalisticoutcomemeasuresa1yearsmartphonestudyinmultiplesclerosis AT leemichelle evaluatingmorenaturalisticoutcomemeasuresa1yearsmartphonestudyinmultiplesclerosis AT legedzaanna evaluatingmorenaturalisticoutcomemeasuresa1yearsmartphonestudyinmultiplesclerosis AT paskavitzjames evaluatingmorenaturalisticoutcomemeasuresa1yearsmartphonestudyinmultiplesclerosis AT prasadsashank evaluatingmorenaturalisticoutcomemeasuresa1yearsmartphonestudyinmultiplesclerosis AT richertjohn evaluatingmorenaturalisticoutcomemeasuresa1yearsmartphonestudyinmultiplesclerosis AT robbinsallison evaluatingmorenaturalisticoutcomemeasuresa1yearsmartphonestudyinmultiplesclerosis AT robertssusan evaluatingmorenaturalisticoutcomemeasuresa1yearsmartphonestudyinmultiplesclerosis AT weinerhoward evaluatingmorenaturalisticoutcomemeasuresa1yearsmartphonestudyinmultiplesclerosis AT ramachandranravi evaluatingmorenaturalisticoutcomemeasuresa1yearsmartphonestudyinmultiplesclerosis AT botfieldmartyn evaluatingmorenaturalisticoutcomemeasuresa1yearsmartphonestudyinmultiplesclerosis AT dejagerphilipl evaluatingmorenaturalisticoutcomemeasuresa1yearsmartphonestudyinmultiplesclerosis |